Using imaging mass spectrometry to accurately diagnose fabry's disease

Circulation Journal

Volumn 75, Issue 1, 2011, Pages 221-223

  Onoue, Kenji ^a,b   Zaima, Nobuhiro ^b   Sugiura, Yuki ^a,b   Isojima, Takuya ^a   Okayama, Satoshi ^a   Horii, Manabu ^a   Akai, Yasuhiro ^a   Uemura, Shiro ^a   Takemura, Genzou ^c   Sakuraba, Hitoshi ^d   Sakaguchi, Yasuhiro ^a   Setou, Mitsutoshi ^b   Saito, Yoshihiko ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSIDASE; GLOBOTRIAOSYLCERAMIDE;

ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; ENZYME ACTIVITY; ENZYME ASSAY; FABRY DISEASE; HUMAN; IMAGING MASS SPECTROMETRY; MASS SPECTROMETRY; MOLECULAR IMAGING; NONHUMAN; SENSITIVITY AND SPECIFICITY;

AGED; ANIMALS; BIOPSY; DISEASE MODELS, ANIMAL; ENDOCARDIUM; FABRY DISEASE; HUMANS; MALE; MASS SPECTROMETRY; MICE; MOLECULAR WEIGHT; TRIHEXOSYLCERAMIDES;

EID: 78651238638     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0767     Document Type: Article

References (10)

1. Zarate YA, Hopkin RJ. Fabry's disease. Lancet 2008; 372: 1427-1435.
2. Feingold KR. The role of epidermal lipids in cutaneous permeability barrier homeostasis. J Lipid Res 2007; 48: 2531-2546.
3. Suzuki T. Cardiovascular diagnostic biomarkers. Circ J 2009; 73: 806-809.
4. Asakura M, Kitakaze M. Global gene expression profling in the failing myocardium. Circ J 2009; 73: 1568-1576.
5. Shimma S, Sugiura Y, Hayasaka T, Zaima N, Matsumoto M, Setou M. Mass imaging and identification of biomolecules with MALDI-QIT-TOF-based system. Anal Chem 2008; 80: 878-885.
6. Ohshima T, Murray GJ, Swaim WD, Longenecker G, Quirk JM, Cardarelli CO, et al. Alpha-Galactosidase A defcient mice: A model of Fabry disease. Proc Natl Acad Sci USA 1997; 94: 2540-2544.
7. Harada T, Yuba-Kubo A, Sugiura Y, Zaima N, Hayasaka T, Goto-Inoue N, et al. Visualization of volatile substances in different organelles with an atmospheric-pressure mass microscope. Anal Chem 2009; 81: 9153-9157.
8. Touboul D, Roy S, Germain DP, Baillet A, Brion F, Prognon P, et al. Fast fingerprinting by MALDI-TOF mass spectrometry of urinary sediment glycosphingolipids in Fabry disease. Anal Bioanal Chem 2005; 382: 1209-1216.
9. Nakao S, Takenaka T, Maeda M, Kodama C, Tanaka A, Tahara M, et al. An atypical variant of Fabry's disease in men with left ventricular hypertrophy. N Engl J Med 1995; 333: 288-293.
10. Kimura A. Molecular etiology and pathogenesis of hereditary cardiomyopathy. Circ J 2008; 72(Suppl): A-38-A-48.